Pharmaceutical Executive November 3, 2025
Nicholas Jacobus, Raj Indupuri

Raj Indupuri, CEO, eClinical Solutions, touches on AI’s transformation of pharma by streamlining clinical development processes, automating data management, accelerating cycle times, and improving decision-making across trials.

Pharmaceutical Executive: How do you see AI transforming the pharmaceutical industry?

Raj Indupuri: So in terms of advancements the last few years with AI, the promise of AI, I would say the last 12 to 18 months have been more compelling in terms of how the latest advancements will impact drug development, and one of the biggest challenges we have with development is both the increased complexity with protocols and study design and also the amount of data that we continue to collect. Just recently, there was research from Tufts, so in 2012...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Biotechnology, Interview / Q&A, Pharma, Pharma / Biotech, Technology, Trends
Infographic: ECRI’s Top 10 Tech Hazards of 2026
Doctors Increasingly See AI Scribes in a Positive Light. But Hiccups Persist.
The Download: OpenAI’s plans for science, and chatbot age verification
AI Personas Of Synthetic Clients Spurs Systematic Uplift Of Mental Health Therapeutic Skills
Models that improve on their own are AI's next big thing

Share Article